.jpeg){kind=spacer}
Novo Nordisk India’s proposal to discontinue several recombinant DNA (rDNA) origin insulin products from the Indian market has been approved by the Subject Expert Committee
India is planning to increase pharmaceutical exports to Russia, the Netherlands and Brazil, diversifying its markets beyond the United States, which remains its largest buyer. Two industry sources confirmed the move, highlighting tariff-related uncer
The health and wellness industry, Zydus Wellness Limited, announced that its wholly owned subsidiary, Alidac UK Limited
India is scheduled to overhaul the regulations under the Biological Diversity Act, 2002 with the intention of boosting the ayurvedic medicine
Bayer has announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for gadoquatrane, an investigational macrocyclic gadolinium-based contrast agent
Shilpa Medicare Limited has finalized a definitive agreement with Pharmaceutical Industries & Biological Products (PPI), a leading enterprise in Saudi Arabia, through its subsidiary Koanna International FZ LLC
Biocon has announced that its wholly owned subsidiary, Biocon Pharma Limited has received Tentative Approval from the United States Food and Drug Administration (USFDA)
Terumo India, the Indian subsidiary of Terumo Corporation (TSE: 4543), a global leader in medical technology, has launched Terufusion Advanced Infusion Systems in India for the first time.
Minister of State for Health and Family Welfare, Prataprao Jadhav, stated that the major advances made so far under the Pradhan Mantri Swasthya Suraksha Yojana
AbbVie completed the purchase of Capstan Therapeutics further bolstering its advanced cell and gene therapies position. Capstan is now officially a part of AbbVie.
.jpg)
, CDSCO.jpg)